RGT-490

· Regor Pharmaceuticals Inc.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for RGT-490, covering 2026-04-21 to 2026-04-21. Get the full timeline:

Most recent: Clinical Trial Update: Study of RGT-490 in Patients With PIK3CA-Mutated Advanced Solid Tumors [Phase 1]